Cancer With POLE Exonucleasic Domain Mutation
1 clinical trials · Condition
◉ Watch Cancer With POLE Exonucleasic Domain Mutation
| Record | Firm | Date |
|---|---|---|
| Secured Access to Nivolumab for Adult Patients With Selected Rare Cancer Types (NCT03012581) | UNICANCER | 2017-06-16 |
Track Cancer With POLE Exonucleasic Domain Mutation automatically
Every clearance here is in the API, with alerts when new ones post.